Turtle Beach Corp entered into Term Loan Financing Agreement with Blue Torch Finance, LLC valued at $85,000,000 (effective 2026-04-30).
“On April 30, 2026, Turtle Beach Corporation (the “Company”) entered into a new financing agreement (the “Term Loan Financing Agreement”) by and among the Company, Voyetra Turtle Beach, Inc., a Delaware corporation, as borrower (“VTB”), each subsidiary of the Company listed as a guarantor on the signature pages thereto, the lenders from time to time party thereto, and Blue Torch Finance, LLC (“the “Term Agent”), as administrative agent and collateral agent (“Blue Torch”), pursuant to which Blue Torch made a loan to VTB in the aggregate amount of $85 million (the “Term Loan Facility”), the proceeds of which were used to or will be used to (a) refinance existing indebtedness of the Company and its subsidiaries; (b) for general corporate purposes; and (c) to pay fees and expenses related to the loan transactions.”
AURAAura Biosciences, Inc.
Aura Biosciences, Inc. entered into Repurchase Agreement with Matrix Capital Management Master Fund, LP (effective 2026-04-30).
“On April 30, 2026, Aura Biosciences, Inc. (the “Company”) and Matrix Capital Management Master Fund, LP (“Matrix”) entered into a stock purchase agreement (the “Repurchase Agreement”)”
RMRegional Management Corp.
Regional Management Corp. amended Fourth Amendment to Credit Agreement and Consent with Regions Bank, as administrative agent and securities intermediary (effective 2026-04-28).
“On April 28, 2026, the Company and its wholly-owned subsidiary, Regional Management Receivables VI, LLC (“ RMR VI ”), entered into the Fourth Amendment to Credit Agreement and Consent, dated as of April 28, 2026 (the “ RMR VI Amendment ”), by and among the Company, as servicer, RMR VI, as borrower, the lenders parties thereto, and Regions Bank, as administrative agent and securities intermediary, and Computershare Trust Company, N.A. as resigning securities intermediary.”
RMRegional Management Corp.
Regional Management Corp. amended Amendment No. 8 to Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (effective 2026-04-28).
“On April 28, 2026, the Company and its wholly-owned subsidiary, Regional Management Receivables V, LLC (“ RMR V ”), entered into the Amendment No. 8 to Credit Agreement, dated as of April 28, 2026 (the “ RMR V Amendment ”), by and among the Company, as servicer, RMR V, as borrower, the lenders from time to time parties thereto, JPMorgan Chase Bank, N.A., as administrative agent, and Computershare Trust Company, National Association, as successor by merger to Wells Fargo, acting through its Corporate Trust Services division, including its successors and permitted assigns, as account bank, securities intermediary, and backup servicer.”
RMRegional Management Corp.
Regional Management Corp. amended Amendment No. 8 to the Credit Agreement with Wells Fargo Bank, National Association, as administrative agent (effective 2026-04-28).
“On April 28, 2026, the Company and its wholly-owned subsidiary, Regional Management Receivables IV, LLC (“ RMR IV ”), entered into the Amendment No. 8 to the Credit Agreement, dated as of April 28, 2026 (the “ RMR IV Amendment ”), by and among the Company, as servicer, RMR IV, as borrower, the lenders party thereto, Wells Fargo Bank, National Association (“ Wells Fargo ”), as administrative agent, and Computershare Trust Company, N.A. (as successor to Wells Fargo), acting through its Corporate Trust Services division, as account bank and backup servicer.”
RMRegional Management Corp.
Regional Management Corp. amended First Amendment to the Loan and Security Agreement with Bank of Montreal, as agent (effective 2026-04-28).
“On April 28, 2026, Regional Management Corp. (the “ Company ”) and certain of its subsidiaries entered into the First Amendment to the Loan and Security Agreement (the “ First Amendment ”), by and among the Company and its subsidiaries named as borrowers therein (collectively with the Company, the “ Revolving Borrowers ”), the financial institutions named as lenders therein (the “ Revolving Lenders ”), and Bank of Montreal, as agent (the “ Senior Revolving Agent ”).”
GNLGlobal Net Lease, Inc.
Global Net Lease, Inc. entered into Agreement and Plan of Merger with Modiv Industrial, Inc. and Modiv Operating Partnership, LP (effective 2026-05-03).
“On May 3, 2026, Global Net Lease, Inc. (“ GNL ”), together with its direct and indirect subsidiaries, GNL Motion Merger Sub, LLC (“ REIT Merger Sub ”), Global Net Lease Operating Partnership, L.P. (the “ Operating Partnership ”) and GNL Motion OpCo Merger Sub, LLC (“ Opco Merger Sub ” and, together with GNL, REIT Merger Sub and the Operating Partnership, the “ GNL Parties ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Modiv Industrial, Inc. (the “ Modiv ”) and Modiv Operating Partnership, LP (the “ Modiv Operating Partnership ” and, together with Modiv, the “ Modiv Parties ”).”
CHRNEKSO BIONICS HOLDINGS, INC.
EKSO BIONICS HOLDINGS, INC. entered into Securities Purchase Agreement with Applied Parent valued at gross proceeds of approximately $15.75 million (effective 2026-05-01).
“the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Applied Parent (the “APLD Parent PIPE Investment”), pursuant to which the Company agreed to sell and issue to Applied Parent 1,311,407 shares of Common Stock (the “Private Placement Shares”).”
SENSSenseonics Holdings, Inc.
Senseonics Holdings, Inc. amended Second Amendment to Loan and Security Agreement with Hercules Capital, Inc. and the Lenders valued at up to $140.0 million (effective 2026-05-01).
“On May 1, 2026, Senseonics Holdings, Inc. (the “Company”) together with several of its wholly-owned subsidiaries (collectively, “Senseonics”) entered into a Second Amendment to Loan and Security Agreement (the “Second Amendment”) with the several financial institutions or entities party thereto (collectively, the “Lenders”) and Hercules Capital, Inc., a Maryland corporation (the “Agent”), in its capacity as administrative agent and collateral agent for itself and the Lenders, which further amends the Company’s existing Loan and Security Agreement”
MDVMODIV INDUSTRIAL, INC.
MODIV INDUSTRIAL, INC. entered into Agreement and Plan of Merger with Global Net Lease, Inc., GNL Motion Merger Sub, LLC, Global Net Lease Operating Partnership, L.P., GNL Motion OpCo Merger Sub, LLC (effective 2026-05-03).
“On May 3, 2026, Modiv Industrial, Inc. (the “ Company ”) and Modiv Operating Partnership, LP (the “ Operating Partnership ” and, together with the Company, the “ Company Parties ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Global Net Lease, Inc. (“ GNL ”), GNL Motion Merger Sub, LLC (“ GNL Merger Sub ”), Global Net Lease Operating Partnership, L.P. (the “ GNL Operating Partnership ”) and GNL Motion OpCo Merger Sub, LLC (“ Opco Merger Sub ” and, together with GNL, GNL Merger Sub and the GNL Operating Partnership, the “ GNL Parties ”).”
AAAlcoa Corp
Alcoa Corp amended Amendment No. 3 to the Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at $1.25 billion revolving credit facility; maturity extended to June 27, 2028 (effective 2026-05-04).
“On May 4, 2026, Alcoa Corporation (the “Company”), Alcoa Nederland Holding B.V., a wholly owned subsidiary of the Company (the “Borrower”), and certain subsidiaries of the Company, entered into Amendment No. 3 (“Amendment No. 3”) to the Revolving Credit Agreement, dated as of September 16, 2016, as amended as of October 26, 2016, as amended and restated as of November 14, 2017, as amended and restated as of November 21, 2018, as amended as of August 16, 2019, as amended as of April 21, 2020, as amended as of June 24, 2020, as amended as of March 4, 2021, as amended and restated as of June 27, 2022, as amended as of January 17, 2024 and as amended as of August 4, 2025 (the “Original Revolving Credit Agreement”), in each case, with a syndicate of lenders and issuers named therein, and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”) for the lenders and issuers.”
ECVTEcovyst Inc.
Ecovyst Inc. entered into Share Purchase Agreement with INEOS Calabrian Holdings Limited and INEOS Calabrian Canada Holdings Limited valued at $190 million (effective 2026-05-01).
“On May 1, 2026, Ecovyst Inc. (the “Company”), through its wholly owned subsidiaries New Structure Subco Inc. (the “US Purchaser”) and EV Industrial Chemical Subsidiary Holdings Inc. (the “Canadian Purchaser” and, together with the US Purchaser, the “Purchasers”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with INEOS Calabrian Holdings Limited (the “US Seller”) and INEOS Calabrian Canada Holdings Limited (the “Canadian Seller” and, together with the US Seller, the “Sellers”), pursuant to which the Purchasers will acquire the entire issued share capital of INEOS Calabrian Holdings Corp. (the “US Target”) and INEOS Calabrian Corporation Canada, Inc. (the “Canadian Target”) (the “Transaction”).”
CNSPCNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. entered into Registration Rights Agreement (effective 2026-05-04).
“In connection with the Purchase Agreement, the Company entered into a Registration Rights Agreement (“Registration Rights Agreement”) and agreed to file a registration statement (the “Registration Statement”) registering the resale of the Common Stock and the Common Stock underlying the Pre-Funded Warrants, within 15 days following the Closing Date”
CNSPCNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. entered into Placement Agreement with A.G.P./Alliance Global Partners valued at 7.0% of the gross proceeds (effective 2026-05-04).
“On May 4, 2026, the Company entered into a placement agency agreement (the “Placement Agreement”) with A.G.P./Alliance Global Partners (the “Placement Agent”), pursuant to which the Company agreed to pay the Placement Agent an aggregate cash fee equal to 7.0% of the gross proceeds received by the Company from the sale of the securities in the transaction.”
CNSPCNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. entered into Securities Purchase Agreement with institutional investors valued at $22.5 million (effective 2026-05-04).
“On May 4, 2026, CNS Pharmaceuticals, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with institutional investors (the “Investors”), pursuant to which the Investors purchased in a private placement: (i) 650,000 shares of the Company’s common stock, $0.001 par value per share (“Common Stock”) at a purchase price of $2.30 per share; and (ii) pre-funded warrants to purchase 9,143,479 shares of the Common Stock (the “Pre-Funded Warrants”) at a purchase price of $2.299 per Pre-Funded Warrant (the “Offering”).”
RLYBRallybio Corp
Rallybio Corp terminated Agreement and Plan of Merger and Reorganization with Candid Therapeutics, Inc. valued at $50,000,000 Parent Termination Fee (effective 2026-05-03).
“On May 3, 2026, Candid terminated the Merger Agreement concurrently with entering into a Permitted Alternative Agreement (as defined in the Merger Agreement) with UCB S.A. (“ UCB ”).”
OBAIOur Bond, Inc.
Our Bond, Inc. entered into Note with Ascent Partners Fund, LLC valued at principal amount of $1,000,000 (effective 2026-05-04).
“Also on May 4, 2026, we issued a Promissory Note to Ascent Partners Fund, LLC in the principal amount of $1,000,000 (the “Note”).”
OBAIOur Bond, Inc.
Our Bond, Inc. amended Warrant Amendment with Ascent Partners Fund LLC (effective 2026-05-04).
“Also on May 4, 2026, we entered into an Amendment (the “Warrant Amendment”) to the common stock purchase warrants (the “Warrants”) held by Ascent.”
OBAIOur Bond, Inc.
Our Bond, Inc. amended Equity Line Amendment with Ascent Partners Fund LLC valued at from $300 million to $50 million (effective 2026-05-04).
“On May 4, 2026, Our Bond, Inc., a Nevada corporation (“we,” “us,” “our” or the “Company”) entered into Amendment No. 3 (the “Equity Line Amendment”) to the Securities Purchase Agreement with Ascent Partners Fund LLC (“Ascent”) dated October 27, 2025, as amended (the “Equity Line SPA”).”
CABACabaletta Bio, Inc.
Cabaletta Bio, Inc. entered into Underwriting Agreement with TD Securities (USA) LLC, Guggenheim Securities, LLC and Cantor Fitzgerald & Co. valued at $2.90 per share (effective 2026-05-04).
“On May 4, 2026, Cabaletta Bio, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with TD Securities (USA) LLC, Guggenheim Securities, LLC and Cantor Fitzgerald & Co. (collectively, the “Underwriters”), relating to an underwritten registered direct offering (the “Offering”) of 51,725,000 shares (the “Shares”) of the Company’s common stock, $0.00001 par value per share (the “Common Stock”).”
BYNObyNordic Acquisition Corp
byNordic Acquisition Corp entered into Note with Achilles Capital AB valued at $250,000 (effective 2025-04-29).
“On April 29, 2025, byNordic Acquisition Corporation (“ BYNO ”, the “ Company ”) issued a promissory note (the “Note”) in the principal amount of $250,000 to Achilles Capital AB (the “ Lender ”), an affiliate of Water by Nordic AB, the Company’s sponsor.”
ASRTAssertio Holdings, Inc.
Assertio Holdings, Inc. amended Amended and Restated Agreement and Plan of Merger with Garda Therapeutics, Inc. and Audi Merger Sub, Inc. (effective 2026-05-01).
“On May 1, 2026, Assertio Holdings, Inc. (the “ Company ” or “ Assertio ”) entered into an Amended and Restated Agreement and Plan of Merger (the “ Amended and Restated Merger Agreement ”) with Garda Therapeutics, Inc., a Delaware corporation (“ Parent ”), and Audi Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Purchaser ”), which amends and restates in its entirety the Agreement and Plan of Merger, dated as of April 8, 2026 (the “ Original Merger Agreement ”), by and among the Company, Parent and Purchaser.”
GBTGGlobal Business Travel Group, Inc.
Global Business Travel Group, Inc. entered into "Merger Agreement" with Gaia Purchaser, Inc., Gaia Merger Sub, Inc. (effective 2026-05-02).
“On May 2, 2026, Global Business Travel Group, Inc., a Delaware corporation (the " Company "), entered into an Agreement and Plan of Merger (the " Merger Agreement ") with Gaia Purchaser, Inc., a Delaware corporation (" Parent "), and Gaia Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (" Merger Sub ")”
UHGUnited Homes Group, Inc.
United Homes Group, Inc. terminated Credit Agreement with Kennedy Lewis Agency Partners LLC and other lenders.
“and (ii) that certain Credit Agreement, dated as of December 11, 2024 (as amended from time to time), among the Company, Great Southern Homes, Inc., Rosewood Communities, Inc., Kennedy Lewis Agency Partners LLC, the lenders party thereto and the other parties party thereto”
UHGUnited Homes Group, Inc.
United Homes Group, Inc. terminated Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, and other lenders.
“the Company repaid all loans, indebtedness, and other obligations, terminated all credit commitments outstanding, and terminated and released all guarantees in respect thereof and all liens on the assets and property of the Company and its applicable subsidiaries securing such indebtedness, as applicable, under (i) that certain Second Amended and Restated Credit Agreement, dated as of August 10, 2023 (as amended from time to time), among the Company, Great Southern Homes, Inc., Rosewood Communities, Inc., Wells Fargo Bank, National Association, the lenders party thereto and the other parties party thereto”
SABSSAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. entered into Master Manufacturing Services Agreement with Emergent BioSolutions Canada Inc. valued at minimum aggregate spend following any FDA approval equal to $36 million (effective 2026-04-28).
“On April 28, 2026 (the “Effective Date”), SAB Biotherapeutics, Inc., a Delaware corporation (the “Company” or “SAB BIO”) entered into a Master Manufacturing Services Agreement (the “MSA”) with Emergent BioSolutions Canada Inc. (“Emergent”).”
NKGen Biotech, Inc.
NKGen Biotech, Inc. amended Omnibus Amendment to Secured Convertible Loan Agreement and Other Loan Documents with AlpineBrook Capital GP I Limited valued at principal amount of $607,200 (effective 2026-04-28).
“On April 28, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into an Omnibus Amendment to Secured Convertible Loan Agreement and Other Loan Documents (the “ Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).”
FSHPFlag Ship Acquisition Corp
Flag Ship Acquisition Corp terminated Agreement and Plan of Merger with Great Future Technology Inc. and GFT Merger Sub Limited valued at Mutual termination of the Agreement and Plan of Merger (effective 2026-05-03).
“On May 3, 2026, pursuant to the GFT Merger Agreement, the parties to the Merger Agreement entered into a Mutual Termination of Agreement (the “Termination Agreement”), pursuant to which, among other things, the parties agreed to mutually terminate the GFT Merger Agreement.”
CBDW1606 CORP.
1606 CORP. entered into Agreement and Plan of Stock Exchange with Sim Agro Inc. (effective 2026-05-02).
“On May 2, 2026, 1606 Corp., a Nevada corporation (the “ Company ”), and Sim Agro Inc., a Texas corporation (“ Sim Agro ”), entered into an Agreement and Plan of Stock Exchange (the “ Agreement ”), pursuant to which the Company will acquire a majority interest in Sim Agro through a strategic stock exchange transaction.”
MGAMMobile Global Esports, Inc.
Mobile Global Esports, Inc. entered into Securities Purchase Agreement with an investor valued at $130,000 (effective 2026-05-01).
“On May 1, 2026, Mobile Global Esports, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an investor, pursuant to which the Company issued a convertible promissory note in the aggregate principal amount of $130,000, of which $13,000 is original issue discount (the “Note”).”
APUSApimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. entered into Confidential Settlement and Mutual Release Agreement with Inscobee Inc. and Apimeds Inc. (the Inscobee Parties) (effective 2026-04-24).
“On April 24, 2026, Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the “ Company ”), MindWave Innovations Inc, a Delaware corporation and a wholly owned subsidiary of the Company (“ MindWave ”), and Lokahi Therapeutics, Inc., a Nevada corporation (“ Lokahi ” and, together with the Company and MindWave, the “ Company Parties ”), together with Erik Emerson (“ Emerson ”), individually and in his capacity as Bio Business Representative under the Agreement and Plan of Merger, dated December 1, 2025 (the “ Merger Agreement ”), entered into a Confidential Settlement and Mutual Release Agreement (the “ Settlement Agreement ”), with Inscobee Inc., a South Korean corporation (“ Inscobee ”), and Apimeds Inc., a South Korean corporation and wholly owned subsidiary of Inscobee (“ Apimeds Korea ”, together with Inscobee, the “ Inscobee Parties ”).”
SBXDSilverBox Corp IV
SilverBox Corp IV amended First Amendment (effective 2026-05-01).
“On May 1, 2026, the parties to the Business Combination Agreement entered into the First Amendment to the Business Combination Agreement (the “First Amendment”), which amends the Business Combination Agreement to extend the Outside Date from May 6, 2026 to August 6, 2026.”
SAFXXCF Global, Inc.
XCF Global, Inc. entered into 2026 Twain Forbearance Agreement with Twain GL XXVIII, LLC (effective 2026-04-29).
“On April 29, 2026, New Rise Renewables Reno, LLC (“ New Rise Reno ”), a subsidiary of XCF Global, Inc. (“ XCF ” or the “ Company ”), and Twain GL XXVIII, LLC (“ Twain ”) entered into a Forbearance Agreement (the “ 2026 Twain Forbearance Agreement ”)”
WGRXWellgistics Health, Inc.
Wellgistics Health, Inc. amended Amended Settlement Agreement with Silverback Capital Corporation (effective 2026-02-09).
“On February 9, 2026, Wellgistics Health, Inc. (the “Company”) entered into an Amended Settlement Agreement (the “Amended Settlement Agreement”) with Silverback Capital Corporation, which amended that certain Settlement Agreement previously referenced in the Original Report (the “Original Settlement Agreement”).”
BPACBlueport Acquisition Ltd
Blueport Acquisition Ltd entered into Agreement and Plan of Merger with SINGAUTO Inc. valued at $1,200,000,000 (effective 2026-05-01).
“On May 1, 2026, Blueport Acquisition Ltd, a Cayman Islands exempted company (the “ Parent ” or “ BPAC ”), entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “ Merger Agreement ”) with (i) NeoCryo Inc, a Cayman Islands exempted company and wholly owned subsidiary of Parent (the “ Purchaser ”), (ii) NeoCryo Merger Sub Ltd, a Cayman Islands exempted company and wholly owned subsidiary of Parent (“ Merger Sub ”), and (iii) SINGAUTO Inc., a Cayman Islands exempted company (the “ Company ”).”
Fundrise eREIT, LLC
Fundrise eREIT, LLC entered into Agreement of Merger and Plan of Reorganization with Fundrise Development eREIT, LLC, Fundrise Equity REIT, LLC, Fundrise East Coast Opportunistic REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, Fundrise Midland Opportunistic REIT, LLC, Fundrise West Coast Opportunistic REIT, LLC (effective 2026-04-29).
“On April 29, 2026, Fundrise eREIT, LLC, a Delaware limited liability company, (“Fundrise eREIT”) entered into an Agreement of Merger and Plan of Reorganization (the “Merger Agreement”) by and among the Fundrise eREIT and each of Fundrise Development eREIT, LLC, Fundrise Equity REIT, LLC, Fundrise East Coast Opportunistic REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, Fundrise Midland Opportunistic REIT, LLC and Fundrise West Coast Opportunistic REIT, LLC (each, a “Fundrise Merger Entity” and collectively the “Fundrise Merger Entities”).”
WENCWest Enclave Merger Corp.
West Enclave Merger Corp. entered into Underwriting Agreement with EarlyBirdCapital, Inc. valued at Gross proceeds of $100,000,000 from offering of 10,000,000 units at $10.00 per unit (effective 2026-04-29).
“egistration Statement: • An Underwriting Agreement, dated April 29, 2026, between the Company and EarlyBirdCapital, Inc.”
GCGRGeneral Catalyst Global Resilience Merger Corp.
General Catalyst Global Resilience Merger Corp. entered into Registration and Shareholder Rights Agreement with GCGR Sponsor LLC and certain of the Company’s directors (effective 2026-04-29).
“the Registration and Shareholder Rights Agreement, dated April 29, 2026, among the Company, the Sponsor and certain of the Company’s directors, which provides for customary demand and piggy-back registration rights for the Sponsor and the holders thereunder”
GCGRGeneral Catalyst Global Resilience Merger Corp.
General Catalyst Global Resilience Merger Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-05-01).
“the Warrant Agreement, dated May 1, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”), which sets forth the expiration and exercise price of and procedure for exercising the Warrants”
GCGRGeneral Catalyst Global Resilience Merger Corp.
General Catalyst Global Resilience Merger Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-05-01).
“the Investment Management Trust Agreement, dated May 1, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee, which establishes the trust account that will hold the net proceeds of the IPO and certain of the proceeds of the sale of the Private Placement GRAIL Securities”
GCGRGeneral Catalyst Global Resilience Merger Corp.
General Catalyst Global Resilience Merger Corp. entered into Private Placement GRAIL Securities Purchase Agreement with GCGR Sponsor LLC (effective 2026-04-29).
“the Private Placement GRAIL Securities Purchase Agreement, dated April 29, 2026, between the Company and GCGR Sponsor LLC (the “Sponsor”), pursuant to which the Sponsor purchased 905,000 GRAIL securities in a private placement”
GCGRGeneral Catalyst Global Resilience Merger Corp.
General Catalyst Global Resilience Merger Corp. entered into Underwriting Agreement with Citigroup Global Markets Inc. (effective 2026-04-29).
“the Underwriting Agreement, dated April 29, 2026, among the Company and Citigroup Global Markets Inc., as the sole bookrunning manager, which contains customary representations and warranties and indemnification of the underwriters by the Company”
LSTALISATA THERAPEUTICS, INC.
LISATA THERAPEUTICS, INC. amended Amendment and Waiver with Kuva Labs Inc. and Kuva Acquisition Corp. valued at up to $1.1 million (effective 2026-05-03).
“On May 3, 2026, Lisata Therapeutics, Inc. (the “Company” or “Lisata”) and Kuva Labs Inc., a Delaware corporation (“Parent”), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), entered into an amendment and waiver (the “Amendment and Waiver”) to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (the “Merger Agreement”).”
STKLSunOpta Inc.
SunOpta Inc. terminated Credit Agreement with Bank of America, N.A., as administrative agent, the lenders from time to time party thereto, and the guarantors from time to time party thereto (effective 2026-05-01).
“the Company repaid in full all of its loans and terminated and satisfied in full all outstanding commitments of lenders to lend under that certain Credit Agreement (the “Credit Agreement”) dated as of December 8, 2023”
HUBBHUBBELL INC
HUBBELL INC entered into Agreement with NSI Electrical Buyer, Inc., NSI Buyer, LP valued at $3.0 billion in cash (effective 2026-05-01).
“☐ ITEM 1.01 Entry into a Material Definitive Agreement. On May 1, 2026, Hubbell Incorporated, a Connecticut corporation, and Hubbell Incorporated (Delaware), a Delaware corporation and wholly-owned subsidiary of Hubbell Incorporated, entered into a Stock Purchase Agreement (the “Agreement”), by and among Hubbell Incorporated (Delaware), NSI Electrical Buyer, Inc., a Delaware corporation (the “Company”), NSI Buyer, LP, a Delaware limited partnership (“Seller”), and Hubbell Incorporated, as parent guarantor (together with Hubbell Incorporated (Delaware), “Hubbell”).”
TRTTRIO-TECH INTERNATIONAL
TRIO-TECH INTERNATIONAL entered into Lease with Skygate Technology (M) SDN. BHD. valued at approximately $115,000 per month (effective 2026-06-01).
“entered into a lease agreement (the “ Lease ”) with Skygate Technology (M) SDN. BHD. (the “ Landlord ”), effective as of June 1, 2026,”
LSCCLATTICE SEMICONDUCTOR CORP
LATTICE SEMICONDUCTOR CORP entered into Commitment Letter with Wells Fargo Bank, N.A., Wells Fargo Securities, LLC and Morgan Stanley Senior Funding, Inc. valued at senior secured 364-day term loan facility in an aggregate principal amount of up to $950,000,000 and (effective 2026-05-04).
“the Company entered into a commitment letter (the “Commitment Letter”), dated as of May 4, 2026, with Wells Fargo Bank, N.A., Wells Fargo Securities, LLC and Morgan Stanley Senior Funding, Inc. (the “Commitment Parties”), pursuant to which, subject to the terms and conditions set forth therein, the Commitment Parties have committed to provide a senior secured 364-day term loan facility in an aggregate principal amount of up to $950,000,000 and a senior secured revolving credit facility in an aggregate principal amount of up to $200,000,000 (collectively, the “Senior Secured Credit Facilities”).”
LSCCLATTICE SEMICONDUCTOR CORP
LATTICE SEMICONDUCTOR CORP entered into Registration Rights Agreement with THL AMI Aggregator, LP (effective 2026-05-04).
“In connection with the Acquisition, the Company and THL are entering into a registration rights agreement (the “Registration Rights Agreement”), which provides for customary registration rights following the completion of the Acquisition with respect to the shares of the Company’s common stock to be issued to THL as consideration for the Acquisition.”
LSCCLATTICE SEMICONDUCTOR CORP
LATTICE SEMICONDUCTOR CORP entered into Agreement and Plan of Merger with AMI TopCo, Inc. and THL AMI Aggregator, LP valued at $1 billion in cash and approximately $650 million in shares of the Company’s common stock (effective 2026-05-04).
“On May 4, 2026, Lattice Semiconductor Corporation, a Delaware corporation (the “Company”), certain of its wholly owned subsidiaries, AMI TopCo, Inc. (“AMI”) and THL AMI Aggregator, LP (“THL”) (solely in its capacity as the representative of securityholders of AMI) entered into an Agreement and Plan of Merger (the “Merger Agreement”).”
FLEXFLEX LTD.
FLEX LTD. entered into Credit Agreement with Citibank, N.A. valued at $1.45 billion (effective 2026-04-30).
“On April 30, 2026 (the “Closing Date”), Flex Ltd. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”), by and among the Company, as borrower, the lenders party thereto, and Citibank, N.A., as administrative agent, which provides a senior delayed draw term loan credit facility (the “Credit Facility”) in an aggregate commitment amount of $1.45 billion.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.